1. Home
  2. PHAT vs NKLR Comparison

PHAT vs NKLR Comparison

Compare PHAT & NKLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$8.16

Market Cap

676.3M

Sector

Health Care

ML Signal

HOLD

Logo Terra Innovatum Global N.V. Ordinary shares

NKLR

Terra Innovatum Global N.V. Ordinary shares

N/A

Current Price

$4.58

Market Cap

623.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PHAT
NKLR
Founded
2018
2018
Country
United States
Italy
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
676.3M
623.2M
IPO Year
2019
2025

Fundamental Metrics

Financial Performance
Metric
PHAT
NKLR
Price
$8.16
$4.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$19.83
$15.00
AVG Volume (30 Days)
977.2K
229.9K
Earning Date
04-30-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
42.72
N/A
EPS
N/A
N/A
Revenue
$175,110,000.00
N/A
Revenue This Year
$93.04
N/A
Revenue Next Year
$58.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
216.93
N/A
52 Week Low
$8.07
$3.73
52 Week High
$18.31
$12.43

Technical Indicators

Market Signals
Indicator
PHAT
NKLR
Relative Strength Index (RSI) 43.37 38.61
Support Level $8.46 $4.06
Resistance Level $9.74 $5.20
Average True Range (ATR) 0.48 0.37
MACD -0.02 -0.09
Stochastic Oscillator 36.76 0.73

Price Performance

Historical Comparison
PHAT
NKLR

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About NKLR Terra Innovatum Global N.V. Ordinary shares

Terra Innovatum Global NV is a micro modular nuclear solutions company that aims to deliver reliable, low-cost, and zero-carbon power wherever energy demand is present through its first-of-a-kind reactor, SOLO. SOLO is compact yet extremely powerful, with one unit generating 1MWe of power, while designed with the strictest safety characteristics and the ability to run 24/7 without the need to refuel for 15 years. Its modular design aims to achieve maximum energy efficiency while significantly reducing the levelized cost of energy (LCOE). SOLO is built using off-the-shelf components and widely available fuel, low-enriched uranium (LEU), which de-risks its regulatory and commercial pathway.

Share on Social Networks: